Hematopoietic and Lymphoid Cell Neoplasm clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
- Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
- Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors
- Wearable Activity Tracking to Curb Hospitalizations
- Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
- Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
- Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
- The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
- Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hematopoietic and Lymphoid Cell Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.